Amy V. Jones

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Jyoti Nangalia, Charles Massie, E. Joanna Baxter et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Thomas Ernst, Andrew Chase, Joannah Score et al. · Nature Genetics · 2010 · 1.1K citations

Histone Modifications, Chromatin, Chromatin Remodeling +11

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Amy V. Jones · Blood · 2005 · 841 citations · Full text

Mutations and prognosis in primary myelofibrosis

A. M. Vannucchi, T L Lasho, Paola Guglielmelli et al. · Leukemia · 2013 · 739 citations

Hematological Malignancy, Hematology, Pathology +4

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Amy V. Jones, Andrew Chase, Richard T. Silver et al. · Nature Genetics · 2009 · 380 citations · Full text

Hematological Malignancy, Major Risk Factor, Medicine +10